BNR
Burning Rock Biotech Ltd
15.80$
-2.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.1% | +3.7% | +7.9% | -5.1% | -2.0% | +5.6% | +11.6% | -11.4% | -5.4% | -13.3% | +25.0% | – | |
| – | +3.2% | -7.1% | +0.4% | -8.2% | -0.5% | -2.5% | +13.4% | -19.0% | -16.5% | +9.4% | +23.6% | – | |
| – | -9.1% | +9.7% | +11.4% | -3.8% | -2.6% | +8.9% | +11.0% | -8.6% | -1.7% | -19.7% | +25.5% | – | |
| – | -12.6% | -9.8% | -1.6% | -24.3% | +6.2% | -22.6% | +23.2% | -16.7% | -17.1% | -19.9% | +13.4% | – | |
| – | +2.4% | -18.8% | -6.0% | -64.6% | +155.6% | -62.7% | +0.4% | +0.9% | +138.9% | -62.9% | +33.3% | – | |
| – | -7.7% | -13.5% | -2.3% | -36.9% | +32.5% | -34.9% | +6.2% | -3.9% | -5.1% | -11.2% | +19.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -1.4% | +1.4% | +0.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +138.0% | -83.2% | +5.6% | +5.8% | – | – | +8.9% | -13.1% | +307.5% | -73.1% | +23.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -587.8% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.